ACE and interstitial lung disease: In a multivariate analysis using a Cox proportional hazards regression model, it was found that sarcoidosis, non-Hodgkin’s lymphoma, lack of ACE inhibitor use, cirrhosis, and interstitial lung disease significantly increased the risk of elevated ACE levels.